Amelia Lorensia1, Zullies Ikawati2, Tri Murti Andayani2, Daniel Maranatha3
1Department of Clinical pharmacy-Community, Faculty of Pharmacy, University of Surabaya, Jl. Raya Kalirungkut, 60293 Indonesia
2Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy Universitas Gadjah Mada, Sekip Utara Yogyakarta, 55281 Indonesia
3Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, University of Airlangga, General Hospital Dr. Soetomo, Surabaya
Background: Intravenous aminophylline is one of the most frequent exacerbations of asthma therapy in Indonesia. Even abroad, the use of aminophylline / theophylline is often used because of higher and better effectiveness than the first line, ie salbutamol nebulasi.
Objective: To determine the effectiveness of salbutamol mebulasi and aminophylline intravenously on exacerbation of asthma in improving lung function with peak expiratory flow (PEF) value with peak flow meter.
Method: This study used quasi experimental method, with research variable is PEF value. The study was conducted from January 2014 to June 2016. The study subjects were adult patients with asthma exacerbations in hospital in Surabaya, with consecutive sampling method. Test the dependent sample t-test (scale scale) to see the population in one group and test the independent sample t-test (scale scale) to see the differences between groups.
Results: This study activated 27 subjects in group A (intravenous aminophylline) and 30 people in group B (salbutamol nebulasi). The comparison of PEF improvements between the two groups used an independent sample t-test, which had previously been tested for normality with Shapiro Wilk with a p value of 0.001 (group A) and 0.001 (group B) which was not published by parametric tests. And after administration of asthma therapy, there is no number equal to both, both intravenous aminophylline and nebulized salbutamol.
Conclusion: The effectiveness of intravenous aminophylline is no different from salbutamol nebula in the improvement of PEF values.
Keywords: exacerbation of asthma, intravenous aminophylline, salbutamol nebulation, peak expiratory flow